Evidence map›Paper›PMID 26516141›Full record

ArticleThe Journal of infectious diseases2016

Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.

Saad B Omer, Varun K Phadke, Robert A Bednarczyk, Allison T Chamberlain, Jennifer L Brosseau, Walter A Orenstein

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Saad B OmerHubert Department of Global Health Department of Epidemiology, Rollins School of Public Health Department of Pediatrics Emory Vaccine Center, Emory University, Atlanta, Georgia.
Varun K PhadkeDivision of Infectious Diseases, School of Medicine.
Robert A BednarczykHubert Department of Global Health Emory Vaccine Center, Emory University, Atlanta, Georgia.
Allison T ChamberlainDepartment of Epidemiology, Rollins School of Public Health.
Jennifer L BrosseauDepartment of Epidemiology, Rollins School of Public Health.
Walter A OrensteinHubert Department of Global Health Department of Pediatrics Emory Vaccine Center, Emory University, Atlanta, Georgia.

Funding

Training a New Generation of VaccinologistsT32AI074492 · NIAID · EMORY UNIVERSITY · PI Rama Rao Amara, Benjamin A Lopman · 2009 to 2026
$6.4M
NIAID NIH HHS T32 AI074492NIAID NIH HHS T32AI074492
6 · The paper itself

Abstract

backgroundStatins have antiinflammatory effects that may impact vaccine-induced immune responses. We investigated the impact of statin therapy on influenza vaccine effectiveness (VE) against medically attended acute respiratory illness (MAARI).

methodsWe conducted a retrospective cohort study over nine influenza seasons using research databases of a large managed care organization in the United States. Influenza vaccination and statin prescription statuses of cohort members and MAARI cases were ascertained on a per-season basis. Incidence rate ratios (IRRs) of MAARI were estimated using Poisson regression and stratified by statin use. Using a ratio of ratios approach, we compared IRRs from periods during to IRRs from periods before influenza circulation and then used relative IRRs to compute VE.

resultsAfter adjustment for multiple prespecified covariates, the influenza VE against MAARI was lower among statin users than nonusers during periods of local (14.1% vs 22.9%; mean difference, 11.4%; 95% confidence interval [CI], -1.7% to 26.1%) and widespread (12.6% vs 26.2%; mean difference, 18.4%; 95% CI, 2.9%-36.2%) influenza circulation.

conclusionsIn this study, statin therapy was associated with reduced influenza VE against MAARI. Since many cases of MAARI are not caused by influenza, studies of the impact of statins on influenza VE against laboratory-confirmed influenza are needed.

Indexed as

Acute DiseaseAgedAnti-Inflammatory AgentsDrug InteractionsFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInfluenza, HumanInfluenza VaccinesMaleMiddle AgedRespiratory Tract InfectionsRetrospective StudiesAnti-Inflammatory AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsInfluenza Vaccinesinflammationinfluenzamedically attended acute respiratory illnessstatinvaccine effectiveness

Identifiers

PMID26516141
PMCPMC4799662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.